External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder.
May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M.
May M, et al. Among authors: haferkamp a.
J Urol. 2012 Apr;187(4):1210-4. doi: 10.1016/j.juro.2011.11.104. Epub 2012 Feb 14.
J Urol. 2012.
PMID: 22335861